_version_ 1784876553942859776
author Nishikubo, Masashi
Shimomura, Yoshimitsu
Yamamoto, Ryusuke
Yoshioka, Satoshi
Maruoka, Hayato
Nasu, Seiko
Nishioka, Tomomi
Sakizono, Kenji
Mitsuyuki, Satoshi
Kubo, Tomoyo
Okada, Naoki
Nakagawa, Daishi
Kamijo, Kimimori
Imoto, Hiroharu
Nagai, Yuya
Hiramoto, Nobuhiro
Yonetani, Noboru
Kondo, Tadakazu
Miyakoshi, Chisato
Doi, Asako
Ishikawa, Takayuki
author_facet Nishikubo, Masashi
Shimomura, Yoshimitsu
Yamamoto, Ryusuke
Yoshioka, Satoshi
Maruoka, Hayato
Nasu, Seiko
Nishioka, Tomomi
Sakizono, Kenji
Mitsuyuki, Satoshi
Kubo, Tomoyo
Okada, Naoki
Nakagawa, Daishi
Kamijo, Kimimori
Imoto, Hiroharu
Nagai, Yuya
Hiramoto, Nobuhiro
Yonetani, Noboru
Kondo, Tadakazu
Miyakoshi, Chisato
Doi, Asako
Ishikawa, Takayuki
author_sort Nishikubo, Masashi
collection PubMed
description
format Online
Article
Text
id pubmed-9868506
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98685062023-01-23 Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies Nishikubo, Masashi Shimomura, Yoshimitsu Yamamoto, Ryusuke Yoshioka, Satoshi Maruoka, Hayato Nasu, Seiko Nishioka, Tomomi Sakizono, Kenji Mitsuyuki, Satoshi Kubo, Tomoyo Okada, Naoki Nakagawa, Daishi Kamijo, Kimimori Imoto, Hiroharu Nagai, Yuya Hiramoto, Nobuhiro Yonetani, Noboru Kondo, Tadakazu Miyakoshi, Chisato Doi, Asako Ishikawa, Takayuki Blood Cancer J Correspondence Nature Publishing Group UK 2023-01-23 /pmc/articles/PMC9868506/ /pubmed/36690628 http://dx.doi.org/10.1038/s41408-023-00792-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Nishikubo, Masashi
Shimomura, Yoshimitsu
Yamamoto, Ryusuke
Yoshioka, Satoshi
Maruoka, Hayato
Nasu, Seiko
Nishioka, Tomomi
Sakizono, Kenji
Mitsuyuki, Satoshi
Kubo, Tomoyo
Okada, Naoki
Nakagawa, Daishi
Kamijo, Kimimori
Imoto, Hiroharu
Nagai, Yuya
Hiramoto, Nobuhiro
Yonetani, Noboru
Kondo, Tadakazu
Miyakoshi, Chisato
Doi, Asako
Ishikawa, Takayuki
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title_full Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title_fullStr Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title_full_unstemmed Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title_short Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
title_sort humoral and cellular responses after covid-19 booster vaccination in patients recently treated with anti-cd20 antibodies
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868506/
https://www.ncbi.nlm.nih.gov/pubmed/36690628
http://dx.doi.org/10.1038/s41408-023-00792-z
work_keys_str_mv AT nishikubomasashi humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT shimomurayoshimitsu humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT yamamotoryusuke humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT yoshiokasatoshi humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT maruokahayato humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT nasuseiko humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT nishiokatomomi humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT sakizonokenji humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT mitsuyukisatoshi humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT kubotomoyo humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT okadanaoki humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT nakagawadaishi humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT kamijokimimori humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT imotohiroharu humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT nagaiyuya humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT hiramotonobuhiro humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT yonetaninoboru humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT kondotadakazu humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT miyakoshichisato humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT doiasako humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies
AT ishikawatakayuki humoralandcellularresponsesaftercovid19boostervaccinationinpatientsrecentlytreatedwithanticd20antibodies